Astrana Health Updates Corporate Presentation Disclosure

Astrana Health ( (ASTH) ) has shared an announcement.

On May 13, 2025, Astrana Health, Inc. updated its corporate presentation for use in conferences and meetings. The company clarified that the information in the presentation is being furnished and not filed under the Securities Exchange Act of 1934, indicating no liability for the content, and it will not be incorporated into any future filings.

The most recent analyst rating on (ASTH) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Astrana Health stock, see the ASTH Stock Forecast page.

Spark’s Take on ASTH Stock

According to Spark, TipRanks’ AI Analyst, ASTH is a Outperform.

Astrana Health demonstrates robust financial health, with impressive revenue growth and strategic expansions supporting its future prospects. While technical indicators suggest caution due to current price trends, the company’s positive earnings call and strategic corporate events bolster confidence. However, valuation concerns and potential regulatory challenges temper the outlook, resulting in a balanced overall score.

To see Spark’s full report on ASTH stock, click here.

More about Astrana Health

Average Trading Volume: 328,626

Technical Sentiment Signal: Sell

Current Market Cap: $1.6B

Learn more about ASTH stock on TipRanks’ Stock Analysis page.